文献速递流行病学与生物统计临床试验与 GCP

药物性直立性低血压:随机对照试验的系统评价与荟萃分析

Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials.
PubMed 文献 · PLoS Med · 2021-11-09

该系统评价与荟萃分析检索EMBASE、MEDLINE和Web of Science至2020年11月23日,纳入69项安慰剂对照随机对照试验共27,079名参与者,评估特定药物与直立性低血压的关联。与安慰剂相比,β受体阻滞剂和三环类抗抑郁药与直立性低血压风险升高相关,α受体阻滞剂、抗精神病药和SGLT-2抑制剂与风险升高至多2倍相关,而血管扩张剂无统计学显著差异。

要点

  • β受体阻滞剂和三环类抗抑郁药与直立性低血压风险显著升高相关。
  • α受体阻滞剂、抗精神病药和SGLT-2抑制剂与直立性低血压风险升高至多2倍相关。
  • 血管扩张剂(CCBs、ACE抑制剂/ARBs、SSRIs)与安慰剂相比无统计学显著差异。

核心结论

  • 用于常见疾病(包括抑郁症、糖尿病和下尿路症状)的药物与直立性低血压风险显著升高相关。
  • 引起交感神经抑制的药物与直立性低血压风险显著升高相关,而大多数血管扩张剂与安慰剂相比风险差异较小且无统计学显著性。
  • 作用于直立性血压反射通路多个环节的药物(如交感抑制、血管扩张、心脏抑制效应)可能具有累积风险,提示多重用药个体可能从体位性血压监测中获益。

研究设计与样本

  • 系统评价与荟萃分析,检索EMBASE、MEDLINE和Web of Science数据库自建库至2020年11月23日。
  • 纳入标准为任何药物报告直立性低血压作为不良事件的安慰剂对照随机对照试验,对象为成人(≥18岁)。
  • 共纳入69项随机对照试验,包含27,079名参与者;使用RoB 2工具评估偏倚风险,采用固定效应Mantel-Haenszel统计量估计汇总OR,使用GRADE工具总结证据确定性。

主要发现

  • 与安慰剂相比,β受体阻滞剂与直立性低血压风险升高相关(OR 7.76 [95% CI 2.51, 24.03])。
  • 与安慰剂相比,三环类抗抑郁药与直立性低血压风险升高相关(OR 6.30 [95% CI 2.86, 13.91])。
  • 与安慰剂相比,α受体阻滞剂、抗精神病药和SGLT-2抑制剂与直立性低血压风险升高至多2倍相关。
  • 与安慰剂相比,血管扩张剂(CCBs、ACE抑制剂/ARBs、SSRIs)与直立性低血压风险无统计学显著差异。

局限性

  • 数据限于安慰剂对照研究,排除了头对头试验。
  • 许多随机对照试验排除了老年参与者,因此结果在临床实践中老年患者中可能被放大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Drug-induced orthostatic hypotension (OH) is common, and its resulting cerebral hypoperfusion is linked to adverse outcomes including falls, strokes, cognitive impairment, and increased mortality. The extent to which specific medications are associated with OH remains unclear. METHODS AND FINDINGS: We conducted a systematic review and meta-analysis to evaluate the extent to which specific drug groups are associated with OH. EMBASE, MEDLINE, and Web of Science databases were searched from inception through 23 November 2020. Placebo-controlled randomised controlled trials (RCTs) on any drug reporting on OH as an adverse effect in adults (≥18 years) were eligible. Three authors extracted data on the drug, OH, dose, participant characteristics, and study setting. The revised Cochrane risk-of-bias tool for randomised trials (RoB 2) was used to appraise evidence. Summary odds ratios (ORs) were estimated for OH using fixed effects Mantel-Haenszel statistics. We conducted subgroup analysis on validity of OH measurement, drug dose, risk of bias, age, and comorbidity. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool was used to summarise the certainty of evidence. Of 36,940 citations, 69 eligible RCTs were included in the meta-analysis comprising 27,079 participants. Compared with placebo, beta-blockers and tricyclic antidepressants were associated with increased odds of OH (OR 7.76 [95% CI 2.51, 24.03]; OR 6.30 [95% CI 2.86, 13.91]). Alpha-blockers, antipsychotics, and SGLT-2 inhibitors were associated with up to 2-fold increased odds of OH, compared to placebo. There was no statistically significant difference in odds of OH with vasodilators (CCBs, ACE inhibitors/ARBs, SSRIs), compared to placebo. Limitations of this study are as follows: data limited to placebo-controlled studies, (excluding head-to-head trials), many RCTs excluded older participants; therefore results may be amplified in older patients in the clinical setting. The study protocol is publicly available on PROSPERO (CRD42020168697). CONCLUSIONS: Medications prescribed for common conditions (including depression, diabetes, and lower urinary tract symptoms) were associated with significantly increased odds of OH. Drugs causing sympathetic inhibition were associated with significantly increased odds of OH, while most vasodilators were associated with small nonsignificant differences in odds of OH, compared to placebo. Drugs targeting multiple parts of the orthostatic blood pressure (BP) reflex pathway (e.g. sympathetic inhibition, vasodilation, cardio-inhibitory effects) may carry cumulative risk, suggesting that individuals with polypharmacy could benefit from postural BP monitoring.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Bhanu C, Nimmons D, Petersen I, et al. Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials. PLoS Med. 2021. PMID: 34752479. doi:10.1371/journal.pmed.1003821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。